Product Milestones
We always aim at setting the gold standard in healthcare and going above and beyond to stay true to “Caring For Life”
Why Choose Us
Humility
Under promise and over deliver Let your work speak for you Always put ‘we’ before ‘me’ Learn from mistakes
Integrity
Do the right thing with conviction and without fear. Practice honesty, impartiality and fairness at all times
Passion
Infuse energy in everything that you do Walk that extra mile Inspire others Do your best in every situation
Innovation
Strive to implement new ideas & technologies to meet unmet needs Encourage others to think out-of-the-box
Our Products Release
Diversified Specialty and Generics Portfolio We manufacture and market a large basket of pharmaceutical formulations covering a broad spectrum of chronic and acute therapies.
1988
Jagsonpal Pharmaceuticals was the first to introduce the sustained-release form of anti-arthritic drug. Today, Indocap SR is the largest selling brand of Indo-Methacin, enjoying a massive 70% market share of Indomethacin in the country.
1989
Jagsonpal Pharmaceuticals was the first to introduce the sustained-release form of anti-arthritic drug. Today, Indocap SR is the largest selling brand of Indo-Methacin, enjoying a massive 70% market share of Indomethacin in the country.
1999
About twenty years ago, Jagsonpal Pharmaceuticals entered into an exclusive tie-up with an international business conglom-erate, to introduce India to a unique molecule for the very first time. Ly-copene was introduced in an equally unique segment of disease prevention through scavenging of free redicals.
2005
About twenty years ago, Jagsonpal Pharmaceuticals entered into an exclusive tie-up with an international business conglom-erate, to introduce India to a unique molecule for the very first time. Ly-copene was introduced in an equally unique segment of disease prevention through scavenging of free redicals.